HEATHER MILEA: Open Payments
NPI 1104348796 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 13 payments from 7 companies in 2025. Trend: 2023 $343 · 2024 $769 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $120 |
| PFIZER INC. | 4 | $80 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| ABBVIE INC. | 1 | $28 |
| Lundbeck LLC | 1 | $21 |
| ACADIA Pharmaceuticals Inc | 1 | $15 |
Products named: Veozah, REXULTI, SHINGRIX, PREVNAR 20, NURTEC ODT, VYALEV, NUPLAZID.
Industry payments across DE — which companies pay providers there.
